We are live on ! Find out more
CFM

Catalyst Funds Management Portfolio holdings

AUM $591M
1-Year Est. Return 71.09%
This Fund
S&P 500
This Quarter Est. Return
+11.2%
1 Year Est. Return
+71.09%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$591M
AUM Growth
+$160M
Cap. Flow
+$155M
Cap. Flow %
26.27%
Top 10 Hldgs %
18.1%
Holding
732
New
402
Increased
110
Reduced
53
Closed
148

Top Buys

Rank Stock Value
1
MDLN
Medline Inc
MDLN
+$11.5M
2
ARM icon
Arm
ARM
+$10.9M
3
AZN icon
AstraZeneca
AZN
+$10M
4
CSCO icon
Cisco
CSCO
+$8.29M
5
ABBV icon
AbbVie
ABBV
+$7.72M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$24.5M
2
NVDA icon
NVIDIA
NVDA
+$16.4M
3
RVMD icon
Revolution Medicines
RVMD
+$15.9M
4
RIO icon
Rio Tinto
RIO
+$11.5M
5
WMT icon
Walmart Inc
WMT
+$9.5M

Sector Composition

Rank Sector Weight
1 Technology 22.62%
2 Industrials 14.98%
3 Healthcare 13.14%
4 Financials 10.95%
5 Materials 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTCS icon
576
BTCS Inc
BTCS
$52.3M
$17.1K ﹤0.01%
+12,300
New +$25.1K
OMEX icon
577
Odyssey Marine Exploration
OMEX
$45.3M
$16.4K ﹤0.01%
+19,700
New +$33.5K
STEX
578
Streamex Corp
STEX
$79.4M
$15.3K ﹤0.01%
+13,500
New +$34.3K
MAIA icon
579
MAIA Biotechnology
MAIA
$79M
$15.1K ﹤0.01%
+10,800
New +$19.9K
VANI icon
580
Vivani Medical
VANI
$120M
$12.2K ﹤0.01%
+12,200
New +$15.3K
RANI icon
581
Rani Therapeutics
RANI
$101M
$10.9K ﹤0.01%
+14,800
New +$18.9K
UPXI icon
582
Upexi
UPXI
$63.3M
$10.3K ﹤0.01%
+10,500
New +$14.1K
ALIT icon
583
Alight
ALIT
$509M
$9.5K ﹤0.01%
+815
New +$19.4K
QNCX icon
584
Quince Therapeutics
QNCX
$18.1M
$3.04K ﹤0.01%
+150
New +$30.1K
A icon
585
Agilent Technologies
A
$37.7B
– –
-3,100
Closed -$422K
ACN icon
586
Accenture
ACN
$85.7B
– –
-1,200
Closed -$322K
AGL icon
587
Agilon Health
AGL
$2B
– –
-576
Closed -$9.92K
ALGN icon
588
Align Technology
ALGN
$12.4B
– –
-8,300
Closed -$1.3M
ALLE icon
589
Allegion
ALLE
$12B
– –
-2,200
Closed -$350K
AMAT icon
590
Applied Materials
AMAT
$440B
– –
-4,584
Closed -$1.18M
ARIS
591
Aris Mining
ARIS
$3.08B
– –
-14,700
Closed -$239K
ASML icon
592
ASML
ASML
$692B
– –
-700
Closed -$749K
ASTS icon
593
AST SpaceMobile
ASTS
$18.5B
– –
-13,028
Closed -$946K
AXP icon
594
American Express
AXP
$238B
– –
-3,240
Closed -$1.2M
BAM icon
595
Brookfield Asset Management
BAM
$74.1B
– –
-40,278
Closed -$2.11M
BKR icon
596
Baker Hughes
BKR
$56.2B
– –
-9,500
Closed -$433K
BMRN icon
597
BioMarin Pharmaceuticals
BMRN
$11.3B
– –
-20,800
Closed -$1.24M
BR icon
598
Broadridge
BR
$16.7B
– –
-900
Closed -$201K
BZ icon
599
Kanzhun
BZ
$6.88B
– –
-44,600
Closed -$909K
CASY icon
600
Casey's General Stores
CASY
$31.7B
– –
-4,200
Closed -$2.32M
22 23
24
25 26

Similar funds

BBL
Beck Bode LLC Dedham, Massachusetts $591M AUM 37.12% 1-Year Est. Return
BA
Bellwether Advisors Lincoln, Nebraska $590M AUM 35.66% 1-Year Est. Return
DPRC
Deer Park Road Corp Steamboat Springs, Colorado $591M AUM 27.7% 1-Year Est. Return
FL
Fourthstone LLC St Louis, Missouri $590M AUM 29.58% 1-Year Est. Return
MW
Maia Wealth Denver, Colorado $591M AUM 16.31% 1-Year Est. Return
SM
Sunriver Management Greenwich, Connecticut $591M AUM 2.74% 1-Year Est. Return
LBIM
Land & Buildings Investment Management Stamford, Connecticut $591M AUM 10.19% 1-Year Est. Return
MPW
MA Private Wealth San Carlos, California $591M AUM 16.05% 1-Year Est. Return

Catalyst Funds Management's Q1 2026 Portfolio in Review

As of Q1 2026, Catalyst Funds Management held 732 positions worth $591M, up 37% from $431M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Catalyst Funds Management deployed $155M of net new capital in Q1 2026, opening 402 new positions and adding to 110 existing holdings. Its largest new stake was Medline Inc: 259,595 shares worth $11.6M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 28% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Broadcom, an estimated $24.5M trimmed.

  • Catalyst Funds Management's largest Q1 2026 buy was Medline Inc: 259,595 shares worth $11.6M.
  • Catalyst Funds Management added most to AstraZeneca in Q1 2026, an estimated $10M increase.
  • Catalyst Funds Management's biggest Q1 2026 reduction was Broadcom, cutting an estimated $24.5M.
  • Catalyst Funds Management fully exited News Corp Class B in Q1 2026, selling an estimated $5.22M.
  • Catalyst Funds Management's ten largest holdings make up 18% of its $591M portfolio in Q1 2026.
  • Catalyst Funds Management opened 402 new positions and closed 148 in Q1 2026.
  • Catalyst Funds Management's portfolio value rose 37% quarter-over-quarter to $591M.

Based on Catalyst Funds Management's 13F filing for Q1 2026, filed 11 May 2026.